Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
133.5 USD | -1.10% | -4.92% | +0.96% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.96% | 13.58B | |
+18.21% | 125B | |
+13.49% | 108B | |
-7.38% | 24.21B | |
+2.07% | 22.78B | |
-10.79% | 17.96B | |
-41.74% | 16.43B | |
-13.51% | 16.37B | |
+27.84% | 11.66B | |
+88.67% | 9.17B |
- Stock Market
- Equities
- NBIX Stock
- News Neurocrine Biosciences, Inc.
- Morgan Stanley Lifts Price Target on Neurocrine Biosciences to $160 From $150, Sees Upside to Shares Ahead of Mid-Stage Readouts; Overweight Kept